×
Fulgent Genetics SG&A Expenses 2015-2024 | FLGT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Fulgent Genetics sg&a expenses from 2015 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
View More
Fulgent Genetics SG&A Expenses 2015-2024 | FLGT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Fulgent Genetics sg&a expenses from 2015 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
Related Stocks
Company Name
Market
Cap
Tempus AI (TEM)
$9.2B
Inspire Medical Systems (INSP)
$5.7B
Hims & Hers Health (HIMS)
$5.5B
Enovis (ENOV)
$2.6B
Privia Health (PRVA)
$2.6B
IRhythm Technologies (IRTC)
$2.3B
Azenta (AZTA)
$2.2B
Omnicell (OMCL)
$2.1B
10x Genomics (TXG)
$1.7B
Clover Health Investments (CLOV)
$1.7B
Schrodinger (SDGR)
$1.5B
Phreesia (PHR)
$1.1B
Butterfly Network (BFLY)
$690M
Standard BioTools (LAB)
$596M
Talkspace (TALK)
$583M
Definitive Healthcare (DH)
$505M
Health Catalyst (HCAT)
$495M
Pulmonx (LUNG)
$268M
TruBridge (TBRG)
$247M
SOPHiA GENETICS SA (SOPH)
$209M
American Well (AMWL)
$124M
EUDA Health Holdings (EUDA)
$112M
P3 Health Partners (PIII)
$76M
HeartBeam (BEAT)
$74M
111 (YI)
$52M
CareCloud (CCLD)
$46M
Outset Medical (OM)
$44M
SHL Telemedicine (SHLT)
$42M
Zepp Health (ZEPP)
$37M
Movano (MOVE)
$23M